Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Trials|September 8, 2009
Design, statistical analysis and sample size calculation of a phase IIb/III study of linagliptin versus voglibose and placeboYoshiharu Horie, Naoyuki Hayashi, Klaus Dugi, et al.
European Journal of Applied Physiology|April 25, 2006
Cardiovascular responses to static extension and flexion of arms and legsKen Tokizawa, Masaki Mizuno, Naoyuki Hayashi, et al.
The Journal of Physiological Sciences : JPS|April 1, 2014
Cerebral blood flow and neurovascular coupling during static exerciseYuji Yamaguchi, Hideaki Kashima, Yoshiyuki Fukuba, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|February 2, 2013
NBS1 directly activates ATR independently of MRE11 and TOPBP1Masahiko Kobayashi, Naoyuki Hayashi, Minoru Takata, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 4, 2008
Blood flow responses in celiac and superior mesenteric arteries in the initial phase of digestionNami Someya, Masako Yamaoka Endo, Yoshiyuki Fukuba, et al.
Physiological Measurement|November 6, 2007
The limited effect of breathing frequency on blood velocity measurements in renal and superior mesenteric arteriesNami Someya, Masako Yamaoka Endo, Yoshiyuki Fukuba, et al.
The Journal of Biological Chemistry|March 24, 2004
Mutational Analysis of Hepatitis C Virus NS5B in the Subgenomic Replicon Cell CultureYuanyuan Ma, Tetsuro Shimakami, Hong Luo, et al.
Temperature (Austin, Tex.)|March 9, 2026
Effects of protein drink temperature on leg muscle strength and muscle mass during a 4-week training period: A pilot studyKyoko Fujihira, Masaki Takahashi, Atsushi Tahara, et al.
European Journal of Applied Physiology|March 10, 2018
Fluid intake restores retinal blood flow early after exhaustive exercise in healthy subjectsTsukasa Ikemura, Katsuhiko Suzuki, Nobuhiro Nakamura, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 1, 2004
[Pharmacological and clinical profile of telmisartan, a selective angiotensin II type-1 receptor blocker]Motohiko Chachin, Tsuyoshi Ohmura, Naoyuki Hayashi, et al.
Pageof 9